Agree with the OP frustration on limited information on metoprolol succinate pharmacokinetics and bid dosing. Searching today, in January 2024, this is the only relevant thread on the topic, and there are no publications. If you would have it - a personal experience. Taking metoprolol succinate 25mg/day once daily in the morning after breakfast, I found that each morning I had a queasy feeling and racing heartrate until I took the next dose. My specialist cardiologist in Boston recommended bid dosing, even though the formulation is "extended release". Making that switch, I am tolerating therapy again. I believe that it is logical to believe that extended release is not guarantee to have full 24 hour coverage for all patient populations, and twice daily dosing might make sense for some people. Sure, I would like published data to support it. Maybe even in-vitro dissolution profiles, my goodness. However, here is a single first-person attestation that also follows first principals.